Therapeutic option for some patients with von Willebrand disease.
Replaces von Willebrand factor and factor VIII that is missing or ineffective in plasma of patients with von Willebrand disease.
Can be used in all types of von Willebrand disease for bleeding episodes and for prevention bleeding during and after surgery.
Utilization associated with thromboembolic events. derived from human plasma and is associated with risk of transmission of infectious agents.
Most common reactions are allergic-anaphylactic type.